Despite the current immunotherapy era, VEGFR inhibitors maintain effectiveness in metastatic renal cell cancer. Real-world data concerning pazopanib are limited. The aim of this study is to add information about efficacy and safety of pazopanib as first-line treatment in metastatic renal cell cancer patients not enrolled into clinical trials.
-
2020 (v1)PublicationUploaded on: April 14, 2023
-
2024 (v1)Publication
In this communication, we describe a characterization procedure suitable to extract the most relevant design parameters of a large area absorber TES, designed for Cosmic Microwave Background measurements, very similar to those that will be fabricated for the LSPE/SWIPE balloon-borne experiment. This is a large (8 mm diameter) Au-on-SiN...
Uploaded on: July 3, 2024